CSL Behring GmbH (secondary packaging, batch release; manufacturing, primary packaging, quality control)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency). It can also be used to treat acquired deficiency of this factor.
Dosage form: powder and solvent for solution for injection or infusion
Active substance Dosage human blood coagulation factor viii 500 IU ATC: B02BD02
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency). It can also be used to treat acquired deficiency of this factor.
Dosage form: powder and solvent for solution for injection or infusion
Active substance Dosage human blood coagulation factor viii 250 IU ATC: B02BD02
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital deficiency of coagulation factor VIII). It can also be used to treat acquired deficiency of this factor.
Dosage form: powder and solvent for solution for injection or infusion
Active substance Dosage human blood coagulation factor viii 1000 IU ATC: B02BD02